Tsingke Biotech, a leading provider of synthetic biology and nucleic acid solutions, successfully hosted the 2025 Small ...

Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...

Industry experts gather to explore oligonucleotide innovation, delivery strategies, and commercialization pathways BEIJING, July 29, 2025 /PRNewswire/ -- Tsingke Biotech, a leading provider ...

Researchers at Nagoya University in Japan have developed a lipid nanoparticle that delivers mRNA to cells five times more ...

With greater investment to improve the scalability and consistency of manufacturing, EV-based medicine is poised to shape ...

PSC-derived exosomes (iPSC-Exos) are rich in bioactive molecules and have demonstrated promising effects in cardiovascular ...

In this research topic we would like to address the question of what improvements are needed in the treatment of posterior eye disease. These improvements ...

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

Tentative detections of life-linked molecules in a star’s disk suggest planets may form with the ingredients for life already ...

Efficient and targeted delivery of nucleic acids is critical for realizing the full therapeutic potential of gene editing, vaccines and RNA-based drugs, and emerging delivery platforms offer ...

Eyam Health and Switzerland-based Medicines for Malaria Venture (MMV) announced a strategic research partnership to discover ...